Novartis AG - Change In Cash

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-In-Cash" stands at -4.05 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2023.

Novartis AG's third quarter result of 2.90 Billion USD for the item "Change In Cash" represents an increase of 807.32 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of 2.90 Billion USD for the item "Change In Cash" represents a decrease of -49.18 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of -4.05 Billion USD for the item "Change In Cash" represents a decrease of -225.02 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -4.18 Billion United States Dollars compared to the value the year prior.
The 1 year change is -4.18 Billion United States Dollars.
The 3 year change is -5.57 Billion United States Dollars.
The 5 year change is -4.67 Billion United States Dollars.
The 10 year change is 0.26 Billion United States Dollars.

The Serie's long term average value is 0.189 Billion United States Dollars. It's latest available value, on 09/30/2025, is -4.24 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2015, to it's latest available value, on 09/30/2025, is +4.30 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -14.10 Billion.